Profil
Ross Barrow is currently the Chief Executive Officer and Director at Paranta Biosciences Ltd.
He was previously a Non-Executive Director at Acrux Ltd.
from 2012 to 2015.
Postes actifs de Ross Barrow
| Sociétés | Poste | Début |
|---|---|---|
Paranta Biosciences Ltd.
 Paranta Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Paranta Biosciences Ltd. engages in the research and development of novel biotherapeutic. t develops PB01 (recombinant human follistatin-288) for the treatment of fibrotic and inflammatory diseases. The company was founded in 2011 and is headquartered in Richmond, Australia. | Directeur Général | - |
Anciens postes connus de Ross Barrow
| Sociétés | Poste | Fin |
|---|---|---|
| ACRUX LIMITED | Directeur/Membre du Conseil | 27/02/2015 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ACRUX LIMITED | Health Technology |
| Entreprise privées | 1 |
|---|---|
Paranta Biosciences Ltd.
Paranta Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Paranta Biosciences Ltd. engages in the research and development of novel biotherapeutic. t develops PB01 (recombinant human follistatin-288) for the treatment of fibrotic and inflammatory diseases. The company was founded in 2011 and is headquartered in Richmond, Australia. | Health Technology |